Cargando…

Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer

Laminin Subunit Beta 3 (LAMB3) is a transcription factor and participates in the coding of laminin. It plays an important role in cell proliferation, adhesion, and transfer by regulating various target genes and signaling pathways. However, the role of LAMB3 in human pan-cancer immunology and progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanghao, Li, Guoyu, Wang, ZhiYuan, Wang, Weizhou, Wang, Xiaofang, Luo, Xuan, Zhao, Juan, Li, Fangfang, Bian, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415034/
https://www.ncbi.nlm.nih.gov/pubmed/37577750
http://dx.doi.org/10.3389/fmolb.2023.1157970
_version_ 1785087432571486208
author Wang, Yanghao
Li, Guoyu
Wang, ZhiYuan
Wang, Weizhou
Wang, Xiaofang
Luo, Xuan
Zhao, Juan
Li, Fangfang
Bian, Li
author_facet Wang, Yanghao
Li, Guoyu
Wang, ZhiYuan
Wang, Weizhou
Wang, Xiaofang
Luo, Xuan
Zhao, Juan
Li, Fangfang
Bian, Li
author_sort Wang, Yanghao
collection PubMed
description Laminin Subunit Beta 3 (LAMB3) is a transcription factor and participates in the coding of laminin. It plays an important role in cell proliferation, adhesion, and transfer by regulating various target genes and signaling pathways. However, the role of LAMB3 in human pan-cancer immunology and prognosis is still poorly understood. The TCGA, GTEx, CCLE, and HPA databases were utilized for the analysis of LAMB mRNA and protein expression. The expression of LAMB3 in various immune and molecular subtypes of human cancer was examined using the TISIDB database. The prognostic significance of LAMB3 in various cancers and clinical subtypes was investigated using Kaplan-Meier and Cox regression analysis. The relationship between LAMB3 expression, various immune cell infiltration, immune checkpoints, tumor mutational load, microsatellite instability, and DNA methylation was examined using the TCGA database. Clinical samples of four lung cancer cell lines and eight lung cancer cases were collected to confirm the expression of mRNA in lung cancer. In 17 cancers, the mRNA for LAMB3 is expressed differently and has good diagnostic and prognostic value in 22 cancers. Cox regression and Nomogram analysis show that LAMB3 is an independent risk factor for 15 cancers. LAMB3 is implicated in a variety of tumorigenesis and immune-related signaling pathways, according to GO, KEGG, and GSEA results. LAMB3 expression was associated with TMB in 33 cancer types and MSI in 32 cancer types, while in lung cancer LAMB3 expression was strongly associated with immune cell infiltration and negatively correlated with all seven methylated CpG islands. Cellular experiments demonstrated that LAMB3 promotes malignant behavior of tumor cells. Preliminary mechanistic exploration revealed its close association with PD-L1, CTLA4, cell stemness gene CD133 and β-catenin-related signaling pathways. Based on these findings, it appears that LAMB3 could be a potential therapeutic target for immunotherapy and tumor prognosis. Our findings reveal an important role for LAMB3 in different cancer types.
format Online
Article
Text
id pubmed-10415034
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104150342023-08-11 Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer Wang, Yanghao Li, Guoyu Wang, ZhiYuan Wang, Weizhou Wang, Xiaofang Luo, Xuan Zhao, Juan Li, Fangfang Bian, Li Front Mol Biosci Molecular Biosciences Laminin Subunit Beta 3 (LAMB3) is a transcription factor and participates in the coding of laminin. It plays an important role in cell proliferation, adhesion, and transfer by regulating various target genes and signaling pathways. However, the role of LAMB3 in human pan-cancer immunology and prognosis is still poorly understood. The TCGA, GTEx, CCLE, and HPA databases were utilized for the analysis of LAMB mRNA and protein expression. The expression of LAMB3 in various immune and molecular subtypes of human cancer was examined using the TISIDB database. The prognostic significance of LAMB3 in various cancers and clinical subtypes was investigated using Kaplan-Meier and Cox regression analysis. The relationship between LAMB3 expression, various immune cell infiltration, immune checkpoints, tumor mutational load, microsatellite instability, and DNA methylation was examined using the TCGA database. Clinical samples of four lung cancer cell lines and eight lung cancer cases were collected to confirm the expression of mRNA in lung cancer. In 17 cancers, the mRNA for LAMB3 is expressed differently and has good diagnostic and prognostic value in 22 cancers. Cox regression and Nomogram analysis show that LAMB3 is an independent risk factor for 15 cancers. LAMB3 is implicated in a variety of tumorigenesis and immune-related signaling pathways, according to GO, KEGG, and GSEA results. LAMB3 expression was associated with TMB in 33 cancer types and MSI in 32 cancer types, while in lung cancer LAMB3 expression was strongly associated with immune cell infiltration and negatively correlated with all seven methylated CpG islands. Cellular experiments demonstrated that LAMB3 promotes malignant behavior of tumor cells. Preliminary mechanistic exploration revealed its close association with PD-L1, CTLA4, cell stemness gene CD133 and β-catenin-related signaling pathways. Based on these findings, it appears that LAMB3 could be a potential therapeutic target for immunotherapy and tumor prognosis. Our findings reveal an important role for LAMB3 in different cancer types. Frontiers Media S.A. 2023-07-27 /pmc/articles/PMC10415034/ /pubmed/37577750 http://dx.doi.org/10.3389/fmolb.2023.1157970 Text en Copyright © 2023 Wang, Li, Wang, Wang, Wang, Luo, Zhao, Li and Bian. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Wang, Yanghao
Li, Guoyu
Wang, ZhiYuan
Wang, Weizhou
Wang, Xiaofang
Luo, Xuan
Zhao, Juan
Li, Fangfang
Bian, Li
Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer
title Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer
title_full Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer
title_fullStr Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer
title_full_unstemmed Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer
title_short Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer
title_sort multi-omics analysis of lamb3 as a potential immunological and biomarker in pan-cancer
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415034/
https://www.ncbi.nlm.nih.gov/pubmed/37577750
http://dx.doi.org/10.3389/fmolb.2023.1157970
work_keys_str_mv AT wangyanghao multiomicsanalysisoflamb3asapotentialimmunologicalandbiomarkerinpancancer
AT liguoyu multiomicsanalysisoflamb3asapotentialimmunologicalandbiomarkerinpancancer
AT wangzhiyuan multiomicsanalysisoflamb3asapotentialimmunologicalandbiomarkerinpancancer
AT wangweizhou multiomicsanalysisoflamb3asapotentialimmunologicalandbiomarkerinpancancer
AT wangxiaofang multiomicsanalysisoflamb3asapotentialimmunologicalandbiomarkerinpancancer
AT luoxuan multiomicsanalysisoflamb3asapotentialimmunologicalandbiomarkerinpancancer
AT zhaojuan multiomicsanalysisoflamb3asapotentialimmunologicalandbiomarkerinpancancer
AT lifangfang multiomicsanalysisoflamb3asapotentialimmunologicalandbiomarkerinpancancer
AT bianli multiomicsanalysisoflamb3asapotentialimmunologicalandbiomarkerinpancancer